Respiratory Infections
EU PARTNER
US PARTNER
An Introduction to Airway and Lung Infection
The field of airway and lung infection is topical in the wake of the COVID-19 pandemic; SARS-CoV-2 is one of several novel respiratory viruses to emerge in the 21st century. Viruses and bacteria can cause a range of respiratory diseases, including acute bronchitis, the common cold, influenza, respiratory distress syndromes, pertussis, pneumonia and tuberculosis. Symptoms of viral infections may range from being very mild to a severe respiratory illness, and therefore prompt and reliable diagnosis is essential. Antibiotic resistance remains the major challenge in bacterial infection. Emerging approaches include cell-based therapies involving mesenchymal stem cells in the treatment of respiratory infections. However, the multiple challenges involved in developing curative therapies for infections highlight the importance of prevention, and vaccine research is essential.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
